CRISPR Reverses Chemo Resistance in Lung Cancer
CRISPR technology reverses chemotherapy resistance in lung cancer by disabling the NRF2 gene. This improves drug sensitivity and slows tumor growth, offering a novel strategy for resistant cancers.
Immunotherapy & Lymph Nodes: Boosting Cancer Fight
Immunotherapy efficacy can be boosted by preserving lymph nodes, crucial for T cell training. Research suggests lymph node removal during surgery may hinder cancer treatment response. Gut bacteria also influence immunotherapy.
Pancreatic Cancer: Blocking Nutrient Scavenging Improves Treatment
Blocking macropinocytosis, a nutrient-scavenging process used by pancreatic cancer (PDAC) cells, reshapes the tumor microenvironment, enhancing immunotherapy and radiation effectiveness. This improves drug delivery and immune cell access.
New Metal-Free Approach Fights Antibiotic Resistance & Cancer
Researchers developed a metal-free, blue light method using modified carbohydrates (thiosugars) to combat antibiotic-resistant infections, cancer, and gram-negative pathogens like Pseudomonas aeruginosa. This advance enhances drug delivery and reduces toxicity.